BionTech reports sensational progress. Will cancer soon be curable via vaccine injection?

Biotech raises hopes that it has a cancer vaccine against solid tumors in development, BNT211. Phase II is expected to start in 2024. After the Covid vaccine, Biontech needs new revenue streams and cancer vaccines would be a gigantic one! Biontech's rise to fame took place during the Covid-19 pandemic for its mRNA vaccine. But the company's big goal is to fight cancer. Last night, the company presented positive data from a phase I/II trial in advanced solid tumors with its BNT211 vaccine, which included 44 patients. Biontech states in...